Claim Missing Document
Check
Articles

Found 2 Documents
Search

How Does Regular Cow's Milk Consumption Combined With Vitamin D Supplementation Affect Nutritional Status And Growth In Malnourished Children ? : A Systematic Review Putu Ratna Rosalina; Salmawati Maryati
The International Journal of Medical Science and Health Research Vol. 12 No. 7 (2025): The International Journal of Medical Science and Health Research
Publisher : International Medical Journal Corp. Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70070/k79vr975

Abstract

Introduction: Malnutrition in children, particularly in low- and middle-income countries, remains a significant global health issue, impairing physical growth and cognitive development. Cow's milk, rich in essential nutrients, and Vitamin D, crucial for bone health and immune function, are vital for child development. This systematic review evaluates the impact of regular cow's milk consumption combined with Vitamin D supplementation on the nutritional status and growth of malnourished children. Methods: This systematic review adhered to PRISMA 2020 guidelines. Studies were screened based on criteria including: children aged 6 months to 12 years meeting WHO malnutrition criteria; intervention with regular cow's milk (minimum 200ml/day) and Vitamin D supplementation; study duration of 3 months or longer; and study designs such as RCTs, systematic reviews, meta-analyses, or prospective cohort studies. Data were extracted from databases including Pubmed, Semantic Scholar, Sagepub, and Google Scholar. Results: The review included 27 studies. Findings indicated that fortified cow's milk with Vitamin D supplementation generally improved Vitamin D status. For instance, some studies showed serum 25-hydroxyvitamin D levels increased by approximately 20 ng/mL with supplementation. Effects on growth metrics like height and weight were modest and variable, with some studies reporting significant improvements (e.g., height-for-age z-scores, p < 0.0001 ) while others found no significant effect. Interventions combining milk with other nutrient sources like eggs or micronutrient powders showed more pronounced effects on growth (e.g., a 2.62 cm increase in height ). Longer intervention durations (≥6 months) and higher doses (e.g., 600 ml milk daily) were often associated with better outcomes for micronutrient status and growth. Discussion: The evidence suggests that fortified cow's milk and Vitamin D supplementation effectively enhances micronutrient status, particularly Vitamin D levels, in malnourished children. While the direct impact on linear growth and weight gain is modest, comprehensive intervention packages addressing multiple deficiencies simultaneously appear most effective. The variability in growth outcomes underscores the importance of considering baseline nutritional status, intervention duration, and dosage. Conclusion: Fortified cow's milk and Vitamin D supplementation is a valuable strategy for improving micronutrient status in malnourished children, especially Vitamin D levels. Although growth improvements can be modest, integrating this intervention into broader, holistic nutritional programs, particularly with longer durations and adequate dosages, is supported by evidence and crucial for mitigating malnutrition.
EFFECT OF VITAMIN D SUPPLEMENTATION ON CLINICAL OUTCOMES IN CRITICALLY ILL ADULTS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS WITH SUBGROUP ANALYSIS BY BASELINE VITAMIN D STATUS Inri Eunike Sigarlaki; Salmawati Maryati
The International Journal of Medical Science and Health Research Vol. 43 No. 2 (2026): The International Journal of Medical Science and Health Research
Publisher : International Medical Journal Corp. Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70070/t7raxk67

Abstract

Introduction: Vitamin D deficiency is highly prevalent among critically ill patients and has been associated with increased morbidity and mortality. Despite strong biological plausibility and supportive observational data, randomized controlled trials (RCTs) evaluating vitamin D supplementation in this population have yielded inconsistent results. This study aimed to systematically evaluate the effect of vitamin D supplementation on clinical outcomes, particularly mortality, in critically ill adult patients. Methods: A systematic review and meta-analysis of RCTs was conducted in accordance with PRISMA guidelines. Electronic databases (PubMed, Scopus, ScienceDirect, and Cochrane) were searched for studies published between January 2015 and December 2025. Eligible studies included RCTs involving adult critically ill ICU patients receiving vitamin D supplementation compared with placebo. The primary outcome was all-cause mortality. Secondary outcomes included ICU length of stay, hospital length of stay, and duration of mechanical ventilation. Pooled risk ratios (RRs) with 95% confidence intervals (CIs) were calculated using a random-effects model. Risk of bias was assessed using the Cochrane RoB 2 tool. Results: Five RCTs comprising 1,736 critically ill patients (871 in the intervention group and 865 in the control group) were included. Vitamin D supplementation was associated with a no statistically significant difference in mortality between groups (RR 0.74; 95% CI 0.53–1.05; p = 0.09). Substantial heterogeneity was observed (I² = 71.1%, p = 0.008), with a wide prediction interval (0.28–1.96). Larger trials demonstrated neutral effects, whereas smaller studies reported more pronounced benefits, suggesting a potential small-study effect. Secondary outcomes were inconsistently reported and showed variable findings, precluding quantitative synthesis. Discussion: The findings suggest that vitamin D supplementation does not provide a consistent mortality benefit in unselected critically ill populations. The observed heterogeneity, variation in study design, and potential influence of small-study effects contribute to the uncertainty of the overall estimate. While biological plausibility and subgroup signals indicate possible benefit in selected patients, current evidence remains insufficient to support routine use for mortality reduction. Conclusion: Vitamin D supplementation in critically ill adult patients was associated with a non-significant trend toward reduced mortality, with substantial heterogeneity across studies. Routine use of high-dose vitamin D for mortality reduction cannot be recommended based on current evidence. Further large-scale, well-designed trials focusing on clearly defined subgroups are needed.